Literature DB >> 21761146

Gender-specific risk factors for incident gout: a prospective cohort study.

Jiunn-Horng Chen1, Wen-Ting Yeh, Shao-Yuan Chuang, Yi-Ying Wu, Wen-Harn Pan.   

Abstract

Previous reports suggested that gout incidence increased with serum uric acid (sUA) level. In addition to sUA, we aimed to examine the gender-specific risk factors for incident gout. A prospective study was conducted using data of the MJ Health Screening Center and outcome database from Taiwan's National Health Insurance. Cox proportional hazard model was used for risk analysis of incident gout. During a mean follow-up of 7.31 years for 132,556 individuals aged ≥18 years, 1,606 subjects (1,341 men and 265 women) with clinical gout were defined. Hyperuricemia (sUA ≥7.7 mg/dL for men or ≥6.6 mg/dL for women) was the most important risk factor for gout development with a respective hazard ratio of 9.65 (95% confidence level, 8.53-10.9) for men and 9.28 (7.00-12.3) for women. The age-standardized sUA-gout relationship demonstrated a differential impact of sUA level on gout incidence between men and women. Metabolic comorbidities of hypertension, obesity, and hyperlipidemia were significantly associated with gout with respective HR of 1.32 (1.17-1.48), 1.30 (1.15-1.47), and 1.12 (0.99-1.26) for men and 1.34 (1.02-1.77), 2.15 (1.67-2.76), and 1.70 (1.32-2.19) for women. However, the relationship between diabetes and incident gout was not as prominent. The sex difference of sUA-gout relationship and the association between metabolic comorbidities and incident gout were demonstrated. Generalizability of these findings to other ethnic population needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21761146     DOI: 10.1007/s10067-011-1802-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

Review 1.  Pathogenesis of gout.

Authors:  Hyon K Choi; David B Mount; Anthony M Reginato
Journal:  Ann Intern Med       Date:  2005-10-04       Impact factor: 25.391

Review 2.  Diagnosis and management of gout.

Authors:  Martin Underwood
Journal:  BMJ       Date:  2006-06-03

Review 3.  A new classification scheme for hypertension based on relative and absolute risk with implications for treatment and reimbursement.

Authors:  H R Black; J Y Yi
Journal:  Hypertension       Date:  1996-11       Impact factor: 10.190

4.  Sex differences in gout epidemiology: evaluation and treatment.

Authors:  L R Harrold; R A Yood; T R Mikuls; S E Andrade; J Davis; J Fuller; K A Chan; D Roblin; M A Raebel; A Von Worley; R Platt; K G Saag
Journal:  Ann Rheum Dis       Date:  2006-04-27       Impact factor: 19.103

5.  Validity of gout diagnoses in administrative data.

Authors:  Leslie R Harrold; Kenneth G Saag; Robert A Yood; Ted R Mikuls; Susan E Andrade; Hassan Fouayzi; Judith Davis; K Arnold Chan; Marsha A Raebel; Ann Von Worley; Richard Platt
Journal:  Arthritis Rheum       Date:  2007-02-15

6.  Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort.

Authors:  Vidula Bhole; Mary de Vera; M Mushfiqur Rahman; Eswar Krishnan; Hyon Choi
Journal:  Arthritis Rheum       Date:  2010-04

7.  Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study.

Authors:  Jiunn-Horng Chen; Shao-Yuan Chuang; Hsin-Jen Chen; Wen-Ting Yeh; Wen-Harn Pan
Journal:  Arthritis Rheum       Date:  2009-02-15

8.  Body mass index (BMI) as a major factor in the incidence of the metabolic syndrome and its constituents in unaffected Taiwanese from 1998 to 2002.

Authors:  Feng-Yu Yang; Mark L Wahlqvist; Meei-Shyuan Lee
Journal:  Asia Pac J Clin Nutr       Date:  2008       Impact factor: 1.662

9.  All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan.

Authors:  Chi Pang Wen; Ting Yuan David Cheng; Min Kuang Tsai; Yen Chen Chang; Hui Ting Chan; Shan Pou Tsai; Po Huang Chiang; Chih Cheng Hsu; Pei Kun Sung; Yi Hua Hsu; Sung Feng Wen
Journal:  Lancet       Date:  2008-06-28       Impact factor: 79.321

10.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.

Authors:  E W Campion; R J Glynn; L O DeLabry
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

View more
  26 in total

1.  Gout after living kidney donation: correlations with demographic traits and renal complications.

Authors:  Ngan N Lam; Amit X Garg; Dorry L Segev; Mark A Schnitzler; Huiling Xiao; David Axelrod; Daniel C Brennan; Bertram L Kasiske; Janet E Tuttle-Newhall; Krista L Lentine
Journal:  Am J Nephrol       Date:  2015-04-17       Impact factor: 3.754

Review 2.  Gout: a review of nonmodifiable and modifiable risk factors.

Authors:  Lindsey A MacFarlane; Seoyoung C Kim
Journal:  Rheum Dis Clin North Am       Date:  2014-09-02       Impact factor: 2.670

3.  Effects of vitamin C supplementation on gout risk: results from the Physicians' Health Study II trial.

Authors:  Stephen P Juraschek; J Michael Gaziano; Robert J Glynn; Natalya Gomelskaya; Vadim Y Bubes; Julie E Buring; Robert H Shmerling; Howard D Sesso
Journal:  Am J Clin Nutr       Date:  2022-09-02       Impact factor: 8.472

4.  The benchmark dose estimation of reference levels of serum urate for gout.

Authors:  Xiao Chen; Zhongqiu Wang; Na Duan; Wenjing Cui; Xiaoqiang Ding; Taiyi Jin
Journal:  Clin Rheumatol       Date:  2018-08-25       Impact factor: 2.980

Review 5.  Racial and gender disparities among patients with gout.

Authors:  Jasvinder A Singh
Journal:  Curr Rheumatol Rep       Date:  2013-02       Impact factor: 4.592

Review 6.  Body mass index and the risk of gout: a systematic review and dose-response meta-analysis of prospective studies.

Authors:  Dagfinn Aune; Teresa Norat; Lars J Vatten
Journal:  Eur J Nutr       Date:  2014-09-11       Impact factor: 5.614

7.  Effects of a Dietary Approach to Stop Hypertension (DASH) Diet Intervention on Serum Uric Acid in African Americans With Hypertension.

Authors:  Stephen P Juraschek; Karen White; Olive Tang; Hsin-Chieh Yeh; Lisa A Cooper; Edgar R Miller
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-08-21       Impact factor: 4.794

8.  In silico identification of potent pancreatic triacylglycerol lipase inhibitors from traditional Chinese medicine.

Authors:  Kuan-Yu Chen; Su-Sen Chang; Calvin Yu-Chian Chen
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

9.  Serum uric acid and adiposity: deciphering causality using a bidirectional Mendelian randomization approach.

Authors:  Tanica Lyngdoh; Philippe Vuistiner; Pedro Marques-Vidal; Valentin Rousson; Gérard Waeber; Peter Vollenweider; Murielle Bochud
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

10.  Reproductive factors and serum uric acid levels in females from the general population: the KORA F4 study.

Authors:  Doris Stöckl; Angela Döring; Barbara Thorand; Margit Heier; Petra Belcredi; Christa Meisinger
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.